Ernst Heinen

2014

In 2014, Ernst Heinen earned a total compensation of $1.1M as Chief Development Officer at Aratana Therapeutics, a 118% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$101,375
Option Awards$672,826
Salary$302,500
Total$1,076,701

Heinen received $672.8K in option awards, accounting for 62% of the total pay in 2014.

Heinen also received $101.4K in non-equity incentive plan and $302.5K in salary.

Rankings

In 2014, Ernst Heinen's compensation ranked 7,272nd out of 13,032 executives tracked by ExecPay. In other words, Heinen earned more than 44.2% of executives.

ClassificationRankingPercentile
All
7,272
out of 13,032
44th
Division
Manufacturing
2,679
out of 4,965
46th
Major group
Chemicals And Allied Products
909
out of 1,690
46th
Industry group
Drugs
715
out of 1,369
48th
Industry
Pharmaceutical Preparations
550
out of 1,042
47th
Source: SEC filing on April 28, 2015.

Heinen's colleagues

We found four more compensation records of executives who worked with Ernst Heinen at Aratana Therapeutics in 2014.

2014

Steven Peter

Aratana Therapeutics

Chief Executive Officer

2014

Linda Rhodes

Aratana Therapeutics

Chief Scientific Officer

2014

Craig ATooman

Aratana Therapeutics

Chief Financial Officer

2014

Julia Stephanus

Aratana Therapeutics

Chief Commercial Officer

In-depth

You may also like